[4] – Ferrari Richard (CIK 0001034413)

Q: What did Tenon Medical (TNON) report in this Form 4?

A grant of 128,957 RSUs to Director Richard Ferrari on 10/13/2025 .

Q: How do the RSUs for TNON’s director vest?

They vest 50% on 01/01/2026 and 50% on 07/31/2026 .

Q: What does each RSU represent for TNON?

Each RSU represents a contingent right to receive one share of common stock .

Q: What is the ownership form of these RSUs?

The RSUs are reported under direct ownership following the grant.

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Tenon Medical (TNON)Richard Ferrari received 128,957 restricted stock units (RSUs) on October 13, 2025. Each RSU represents a right to receive one share of common stock. The award vests in two equal tranches: 50% on January 1, 2026 and 50% on July 31, 2026. The filing lists the transaction at $0 per unit and shows direct ownership of the RSUs following the grant.

Tenon Medical (TNON)Richard Ferrari ha ricevuto 128.957 unità azionarie limitate (RSU) in data 13 ottobre 2025. Ogni RSU rappresenta un diritto a ricevere una sola azione ordinaria. L'assegnazione matura in due tranche uguali: 50% il 1 gennaio 2026 e 50% il 31 luglio 2026. La documentazione indica la transazione a $0 per unità e mostra proprietà diretta delle RSU dopo l'assegnazione.

Tenon Medical (TNON)Richard Ferrari recibió 128.957 unidades de acciones restringidas (RSU) el 13 de octubre de 2025. Cada RSU representa el derecho a recibir una acción común. El otorgamiento se vence en dos tramos iguales: 50% el 1 de enero de 2026 y 50% el 31 de julio de 2026. La presentación indica la transacción a $0 por unidad y muestra la propiedad directa de las RSU tras el otorgamiento.

텐온 메디컬(TNON)가 리처드 페라리 이사에게 128,957주식매입제한주식(RSU)를 2025년 10월 13일에 수령했다는 Form 4를 제출했습니다. 각 RSU는 보통주 1주를 받을 권리를 나타냅니다. 이 수여는 두 개의 동등한 분할로 입증됩니다: 50%는 2026년 1월 1일에, 50%는 2026년 7월 31일에 취득합니다. 제출서는 거래를 주당 $0으로 목록화하고 수여 후 RSU의 직접 소유를 보여줍니다.

Tenon Medical (TNON) a déposé un Formulaire 4 indiquant que le directeur Richard Ferrari a reçu 128 957 unités d'actions restreintes (RSU) le 13 octobre 2025. Chaque RSU représente un droit de recevoir une action ordinaire. L'attribution vest en deux tranches égales: 50% le 1er janvier 2026 et 50% le 31 juillet 2026. Le dépôt répertorie la transaction à $0 par unité et indique une propriété directe des RSU après l'attribution.

Tenon Medical (TNON) hat ein Formular 4 eingereicht, in dem Direktor Richard Ferrari am 13. Oktober 2025 128.957 Restricted Stock Units (RSUs) erhalten hat. Jede RSU berechtigt zum Erhalt einer Stammaktie. Die Zuweisung vest in zwei gleichen Tranchen: 50% am 1. Januar 2026 und 50% am 31. Juli 2026. Die Einreichung gibt die Transaktion mit $0 pro Einheit an und zeigt direkten Besitz der RSUs nach der Gewährung.

تينون ميديكال (TNON) قد قدمت نموذج 4 يذكر أن المدير ريتشارد فيراري تلقّى 128,957 وحدة أسهم مقيدة (RSU) في 13 أكتوبر 2025. كل RSU تمثل حقاً في تلقي سهم واحد عادي. تتحقق المنحة على مدى فقرتين متساويتين: 50% في 1 يناير 2026 و 50% في 31 يوليو 2026. التسجيـل يدرج الصفقة بسعر $0 لكل وحدة ويظهر الملكية المباشرة لـ RSUs بعد المنحة.

Tenon Medical (TNON) 已提交 Form 4，报告董事 Richard Ferrari 于 2025年10月13日 收取了 128,957份受限股票单位（RSU）。每份 RSU 代表获得一股普通股的权利。该授予分两次等额归属：50% 于 2026年1月1日，50% 于 2026年7月31日。该申报将交易列为每单位 $0，并显示授予后对 RSU 的直接持有。

Positive

None.

Negative

None.

10/15/2025 - 12:00 AM

SEC Form 4

FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number: 3235-0287

Estimated average burden

hours per response: 0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*
Ferrari Richard

(Last) (First) (Middle)

104 COOPER COURT

(Street)
LOS GATOS CA 95032

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Tenon Medical, Inc. [ TNON ] 5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X Director 10% Owner

Officer (give title below) Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)

X Form filed by One Reporting Person

Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)

Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Restricted Stock Units ⁽¹⁾ 10/13/2025 A 128,957 ⁽²⁾ ⁽²⁾ Common Stock 128,957 $0 128,957 D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

2. Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026.

/s/ Richard Ferrari 10/15/2025

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Tenon Medical (TNON) report in this Form 4?

A grant of 128,957 RSUs to Director Richard Ferrari on 10/13/2025.

How do the RSUs for TNON’s director vest?

They vest 50% on 01/01/2026 and 50% on 07/31/2026.

What does each RSU represent for TNON?

Each RSU represents a contingent right to receive one share of common stock.

What price is shown for the RSU transaction?

The filing lists a price of $0 per RSU.

What is the ownership form of these RSUs?

The RSUs are reported under direct ownership following the grant.

Who is the reporting person in TNON’s Form 4?

Director Richard Ferrari.

[4] – Ferrari Richard (CIK 0001034413)

FAQ

What did Tenon Medical (TNON) report in this Form 4?

How do the RSUs for TNON’s director vest?

What does each RSU represent for TNON?

What price is shown for the RSU transaction?

What is the ownership form of these RSUs?

Who is the reporting person in TNON’s Form 4?

NASDAQ:TNON

TNON Rankings

TNON Latest News

TNON Latest SEC Filings

TNON Stock Data

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	10/13/2025		A		128,957		⁽²⁾	⁽²⁾	Common Stock	128,957	$0	128,957	D

	/s/ Richard Ferrari	10/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Trending News

[4] – Ferrari Richard (CIK 0001034413)

FAQ

What did Tenon Medical (TNON) report in this Form 4?

How do the RSUs for TNON’s director vest?

What does each RSU represent for TNON?

What price is shown for the RSU transaction?

What is the ownership form of these RSUs?

Who is the reporting person in TNON’s Form 4?

NASDAQ:TNON

TNON Rankings

TNON Latest News

TNON Latest SEC Filings

TNON Stock Data